BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 21218636)

  • 1. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vinculin and the androgen receptor in prostate cancer: expressions and correlations].
    Zhu LY; Zhong KB; Lu SX; He LY
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):794-8. PubMed ID: 21171262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of sexual hormon receptors in prostatic cancer tissues].
    Ding T; Che WJ; Chen TJ
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):50-2, 56. PubMed ID: 16483160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
    Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
    Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
    Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
    Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
    J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
    Zhen B; Shen Y; Zhang YM; Zhu CH; Liu ZL
    Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of nucleosomal binding protein 1 in normal prostate benign prostate hyperplasia, and prostate cancer and significance thereof].
    Song G; Zhou LQ; Weng M; He Q; He ZS; Hao JR; Pan BN; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1962-5. PubMed ID: 17064590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
    Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
    Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of VEGF in prostate cancer and its correlation with ET-1].
    Zhou WQ; Yin HL; Zhang ZY; Yi XM; Ge JP; Zhou SG; Cheng W; Wei W; Ma HQ; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2008 Nov; 14(11):987-92. PubMed ID: 19102498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and function of AR isoforms in prostate cancer.
    Zeng R; Liu Z; Sun Y; Xu C
    Oncol Rep; 2012 Feb; 27(2):492-8. PubMed ID: 22020793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.
    Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y
    Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG gene expression and its possible significance in prostate cancers.
    Liu Y; Chen Z; Niu N; Chang Q; Deng R; Korteweg C; Gu J
    Prostate; 2012 May; 72(6):690-701. PubMed ID: 22430367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different perforin expression in peripheral blood and prostate tissue in patients with benign prostatic hyperplasia and prostate cancer.
    Tokmadžić VS; Tomaš MI; Sotošek S; Laškarin G; Dominović M; Tulić V; Dorđević G; Sustić A; Mrakovčić-Šutić I
    Scand J Immunol; 2011 Oct; 74(4):368-76. PubMed ID: 21535078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of M3 muscarinic receptor expression in different prostate tissues and its significance.
    Song W; Yuan M; Zhao S
    Saudi Med J; 2009 Aug; 30(8):1010-6. PubMed ID: 19668880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.
    Miyoshi Y; Ishiguro H; Uemura H; Fujinami K; Miyamoto H; Miyoshi Y; Kitamura H; Kubota Y
    Prostate; 2003 Sep; 56(4):280-6. PubMed ID: 12858356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.